Zalutumumab (anti-EGFR), 表皮生长因子受体 erbB1 拮抗剂

CAS: 667901-13-5 货号: Ab183436
有货
级别和纯度: 无动物源 ? 无动物源(Animal Free)—— 不含动物源成分生产,降低污染风险。适用于避免动物源材料的生物制造和培养。 无载体 ? 无载体(Carrier Free)—— 不含添加的载体蛋白/稳定剂。当载体(如 BSA)会干扰偶联或敏感检测时使用。 重组 ? 重组(Recombinant)—— 通过重组表达生产,序列确定、批次稳定。适用于来源明确、无动物源的可重现蛋白。 ExactAb™ ? ExactAb™ —— 阿拉丁强调精准和验证质量的抗体系列。适用于可靠、特异性经验证的抗体应用。 低内毒素 ? 低内毒素级 —— 内毒素降至受控低水平。适用于高内毒素会造成干扰的敏感生物工作。 无叠氮钠 ? 无叠氮(Azide Free)—— 不含叠氮化钠防腐剂。适用于叠氮有毒或有抑制作用的偶联、细胞工作或检测。 已验证 ? 已验证级 —— 发布前在特定应用中确认性能。当需要试剂按声称工作的书面保证时使用。 ≥95%(SDS-PAGE&SEC-HPLC) 见COA
应用
Animal Model, ELISA, Flow Cytometry, Functional Assay
宿主种属
人(Human)
种属反应性
人(Human), 小鼠(Mouse)
亚型
Human IgG1
偶联
Unconjugated
★
规格
库存
价格
数量
100μg
Ab183436-100μg
现货 Stock Image
¥434.90
1mg
Ab183436-1mg
现货 Stock Image
¥2,144.90
5mg
Ab183436-5mg
现货 Stock Image
¥5,002.40
10mg
Ab183436-10mg
期货 Stock Image
¥10,689.90
请输入您要添加的产品数量
🧪
为什么选择此级别

ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述

Zalutumumab (anti-EGFR) 是一种高亲和力的纯人类 IgG1 单克隆抗体,靶向 EGFR。Zalutumumab (anti-EGFR) 与表皮生长因子受体的结构域 III 结合,通过阻断表皮生长因子的结合和干扰受体的活性构象发挥作用。Zalutumumab (anti-EGFR) 与 IgG 及其 Fab 区段的 EC50 值分别为 7 和 19 nM。Zalutumumab (anti-EGFR) 可用于癌症的研究。

Zalutumumab (anti-EGFR) is a high affinity, completely human IgG1 monoclonal antibody targeting EGFR. Zalutumumab (anti-EGFR) binds to domain III of the EGF receptor and acts by blocking the binding of EGF and by sterically interfering with the active conformation of the receptor. Zalutumumab (anti-EGFR) binds with IgG and its Fab fragment with EC50s of 7 and 19 nM, respectively. Zalutumumab (anti-EGFR) can be used for the research of cancer.

规格

产品名称
Zalutumumab (anti-EGFR), 表皮生长因子受体 erbB1 拮抗剂
别名
扎芦木单抗
英文别名
Avian erythroblastic leukemia viral (v erb b) oncogene homolog antibody | Cell growth inhibiting protein 40 antibody | Cell proliferation inducing protein 61 antibody | EGF R antibody | EGFR antibody | EGFR_HUMAN antibody | Epidermal growth factor recepto
规格或纯度
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
生化机理
Receptor tyrosine kinase binding ligands of the EGF family and activating several signaling cascades to convert extracellular cues into appropriate cellular responses. Known ligands include EGF, TGFA/TGF-alpha, amphiregulin, epigen/EPGN, BTC/betacellulin, epiregulin/EREG and HBEGF/heparin-binding EGF. Ligand binding triggers receptor homo- and/or heterodimerization and autophosphorylation on key cytoplasmic residues. The phosphorylated receptor recruits adapter proteins like GRB2 which in turn activates complex downstream signaling cascades. Activates at least 4 major downstream signaling cascades including the RAS-RAF-MEK-ERK, PI3 kinase-AKT, PLCgamma-PKC and STATs modules. May also activate the NF-kappa-B signaling cascade. Also directly phosphorylates other proteins like RGS16, activating its GTPase activity and probably coupling the EGF receptor signaling to the G protein-coupled receptor signaling. Also phosphorylates MUC1 and increases its interaction with SRC and CTNNB1/beta-catenin. Isoform 2 may act as an antagonist of EGF action. Post-translational: Phosphorylation at Ser-695 is partial and occurs only if Thr-693 is phosphorylated. Phosphorylation at Thr-678 and Thr-693 by PRKD1 inhibits EGF-induced MAPK8/JNK1 activation. Dephosphorylation by PTPRJ prevents endocytosis and stabilizes the receptor at the plasma membrane. Autophosphorylation at Tyr-1197 is stimulated by methylation at Arg-1199 and enhances interaction with PTPN6. Autophosphorylation at Tyr-1092 and/or Tyr-1110 recruits STAT3. Dephosphorylated by PTPN1 and PTPN2. Monoubiquitinated and polyubiquitinated upon EGF stimulation; which does not affect tyrosine kinase activity or signaling capacity but may play a role in lysosomal targeting. Polyubiquitin linkage is mainly through 'Lys-63', but linkage through 'Lys-48', 'Lys-11' and 'Lys-29' also occurs. Deubiquitination by OTUD7B prevents degradation. Ubiquitinated by RNF115 and RNF126. Methylated. Methylation at Arg-1199 by PRMT5 stimulates phosphorylation at Tyr-1197.
宿主种属
人(Human)
特异性
EGFR
种属反应性
人(Human),小鼠(Mouse)
偶联
Unconjugated
作用类型
拮抗剂
作用机制
表皮生长因子受体 erbB1 拮抗剂
克隆类型
重组抗体
Format
Whole IgG
亚型
Human IgG1
轻链亚型
kappa
纯化方法
Protein A purified
浓度
见COA
CAS编号和信息
667901-13-5
分子类型
抗体
产品线
生物产品
储存与运输
物理外观
Liquid
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
在 -80℃ 下保存 24 个月。收货后建议分装。避免冷冻/解冻循环。
图片

Zalutumumab (anti-EGFR) (Ab183436) - Flow Cytometry
Flow Cytometry analysis of A431 cells labelling EGFR (red) with Zalutumumab (anti-EGFR) (Ab183436) at 1.0 μg/mL for 1 hour at 4°C. Goat Anti-Human IgG (PE) (Ab175838) at a dilution of 1/1000 was used as the secondary antibody. Blue - Isotype control, human IgG (Ab170213). Black - Unlabelled control, cells without incubation with primary antibody.

Zalutumumab (anti-EGFR) (Ab183436) - SEC
The purity of Zalutumumab (anti-EGFR) (Ab183436) is more than 95% verified by HPLC.

Zalutumumab (anti-EGFR) (Ab183436) - ELISA
Immobilized Recombinant Human EGFR protein (rp176273) at 1.0 μg/mL can bind Zalutumumab (anti-EGFR) (Ab183436) with the EC50 of 30.92 ng/mL.

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

关联靶点(人)
EGFR Tclin 表皮生长因子受体(Epidermal growth factor receptor) (0 活性数据)
活性类型 活性值-log(M) 作用机制 期刊 参考文献(PubMed IDs)
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EGFR Tclin MER intracellular domain/EGFR extracellular domain chimera (2 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EGFR Tclin Protein cereblon/Epidermal growth factor receptor (191 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EGFR Tclin EGFR/PPP1CA (1 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
EGFR Tclin VHL/EGFR (323 活性数据)
活性类型 Relation Activity value Units Action Type 期刊 PubMed Id doi Assay Aladdin ID
作用机制
作用机制 Action Type target ID Target Name Target Type Target Organism Binding Site Name 参考文献
质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到6个结果

批号(Lot Number) 证书类型 货号
ZJ24F1113748 分析证书 Ab183436
ZJ24F1113749 分析证书 Ab183436
ZJ24F1113750 分析证书 Ab183436
ZJ26F0433732 分析证书 Ab183436
ZJ26F0433731 分析证书 Ab183436
ZJ26F0433730 分析证书 Ab183436
溶液计算器

常见问题

什么是「无动物源」?
「无动物源」表示该物料经过加工和检测,适用于特种工业加工。规格侧重于影响该应用性能的杂质——例如,电子应用的金属含量、电池应用的粒度、光学应用的折射率,或对水分敏感工艺的水分含量。
什么是「无载体」?
「无载体」表示该物料经过加工和检测,适用于特种工业加工。规格侧重于影响该应用性能的杂质——例如,电子应用的金属含量、电池应用的粒度、光学应用的折射率,或对水分敏感工艺的水分含量。
本产品应如何储存?
请于?80 °C条件下保存。避免反复冻融。建议按单次用量分装保存。
本产品的 CAS 号、分子式和分子量是多少?
本产品的 CAS 号为 667901-13-5。
本产品如何运输?
本产品采用干冰配冷袋冷冻运输。收货后请立即拆包,并按上述储存条件保存;处理干冰时请戴隔热手套并保持通风。
如何获取批次专用COA?
每个订单都会随附分析证书(COA),您也可以从账户订单历史中下载。如需订购前的COA,请联系您的客户代表,或使用PDP上的"申请COA"按钮——我们将提供代表性批次的COA。
该抗体已验证对哪些物种有反应性?
已验证的反应性列在PDP和每批次的数据表上。我们针对靶标(Zalutumumab (anti-EGFR))最常测试的物种进行验证;未经测试的物种可能存在交叉反应性,但不能保证。如有特定物种咨询,请联系技术支持。

相关产品

Cetuximab (anti-EGFR)-19552,用于ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)各种应用,>95%,表皮生长因子受体抗体
Goat Anti-Human IgG H&L (HRP)-19553,用于WB,ELISA,IHC各种应用
Mouse Anti-Human IgG Antibody-19553,用于ELISA,CLIA各种应用
Mouse Anti-Human IgG H&L (HRP)-19553,用于ELISA各种应用
Mouse Anti-Human IgM Antibody-19553,用于ELISA各种应用
Human IgG-19554,用于WB,CLIA,LF,EIA,PRTIA各种应用,>95%
Panitumumab (anti-EGFR)-19552,用于Flow,ELISA,Functional Assay,Kinetics (BLI),Kinetics (SPR)各种应用,>95%,表皮生长因子受体抗体
Goat Anti-Human IgG Antibody-19553,用于ELISA,CLIA,LFAs,WB and other immunoassay methods各种应用,≥ 95%
Necitumumab (anti-EGFR)-19552,用于ELISA,Functional Assay,Flow cytometry,Kinetics (BLI),Kinetics (SPR)各种应用,>95%,表皮生长因子受体抗体
Depatuxizumab mafodotin (anti-EGFR)-19552,表皮生长因子受体 erbB1 结合剂的结合剂
Nimotuzumab (anti-EGFR)-19552,>95%,表皮生长因子受体 erbB1 抑制剂
Mouse Anti-Human IgA H&L Antibody-19553
Goat Anti-Human IgG (HRP)-19553
Goat Anti-Human IgG (Biotin)-19553
Goat Anti-Human IgG (APC)-19553
Goat Anti-Human IgG (Cy5)-19553
Goat Anti-Human IgG (TRITC)-19553
Goat Anti-Human IgG (PE)-19553
Goat Anti-Human IgG (FITC)-19553
Mouse Anti-Human IgE epsilon chain Antibody-19553
Goat Anti-Human IgG Fc Antibody-19553
Recombinant EGFR Antibody (Biotin)-19552
Recombinant EGFR Antibody (FITC)-19552
Recombinant EGFR Antibody (APC)-19552
Recombinant EGFR Antibody (PE)-19552
Modotuximab (anti-EGFR)-19552,表皮生长因子受体 erbB1 拮抗剂
Imgatuzumab (anti-EGFR)-19552,表皮生长因子受体 erbB1 抑制剂
Matuzumab (anti-EGFR)-19552,表皮生长因子受体 erbB1 抑制剂
Serclutamab (anti-EGFR)-19552
Depatuxizumab (anti-EGFR)-19552,表皮生长因子受体 erbB1 抑制剂
Human IgG2-Kappa-19554
Human IgG3-kappa-19554
EGFR Mouse mAb-19552
EGFR Mouse mAb-19552
Human IgG1-kappa, anti-Spike RBD-19554
Human IgG4-kappa-19554
Goat Anti-Human IgG (AF647)-19553
Goat Anti-Human IgG (AF405)-19553
Human IgG (FITC)-19554
Human IgG (APC)-19554
Human IgG1(P331S/E430G)-kappa, anti-HEL-19554
Human IgG (PE)-19554
Human IgG1(D265A/N297A)-kappa, anti-HEL-19554
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(F405L)-kappa, anti-HEL-19554
Human IgG1(N297Q)-kappa, anti-HEL-19554
Human IgG (Biotin)-19554
Human IgG1(N297S)-kappa, anti-HEL-19554
Human IgG1(E233A/L235A)-kappa, anti-HEL-19554
Human IgG1(K214R/N297A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL-19554
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234F/L235E)-kappa, anti-HEL-19554
Human IgG1(D265A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL-19554
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL-19554
Human IgG1(D270N)-kappa, anti-HEL-19554
Human IgG4(S228P)-kappa, anti-HEL-19554
Human IgG1(N297A)-kappa, anti-HEL-19554
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL-19554
Human IgG1-lambda1, anti-Spike RBD-19554
Human IgG1-lambda2, anti-Spike RBD-19554
Demupitamab (anti-EGFR)-19552
Losatuxizumab (anti-EGFR)-19552
Goat Anti-Human IgG (AF555)-19553
EGFR Mouse mAb (Biotin)-19552
EGFR Mouse mAb (PE)-19552
EGFR Mouse mAb (AF647)-19552
EGFR Mouse mAb (APC)-19552
EGFR Mouse mAb (AF488)-19552
Human IgG1-kappa (AF647), anti-Spike RBD-19554
Human IgG1-kappa (AF405), anti-Spike RBD-19554
Human IgG1-kappa (APC), anti-Spike RBD-19554
Human IgG1-kappa (Biotin), anti-Spike RBD-19554
Human IgG1-kappa (AF700), anti-Spike RBD-19554
Human IgG1-kappa (FITC), anti-Spike RBD-19554
Human IgG1-kappa (AF555), anti-Spike RBD-19554
Centrose patent anti-dysadherin (anti-Dysadherin)-19552
Recombinant EGFR Antibody (Biotin)-19552
Recombinant EGFR Antibody (AF405)-19552
Recombinant EGFR Antibody (AF647)-19552
Recombinant EGFR Antibody (FITC)-19552
Recombinant EGFR Antibody (AF700)-19552
Human IgG (AF647)-19554
Human IgG (AF488)-19554
Human IgG (AF700)-19554
Human IgG (AF405)-19554
Recombinant EGFR Antibody (AF555)-19552
Goat Anti-Human IgG (AF488)-19553
Goat Anti-Human IgG Fc (Cy5)-19553
Goat Anti-Human IgG Fc (AF555)-19553
Goat Anti-Human IgG Fc (TRITC)-19553
Goat Anti-Human IgG Fc (AF700)-19553
Goat Anti-Human IgG Fc (AF405)-19553
Goat Anti-Human IgG Fc (Biotin)-19553
Goat Anti-Human IgG Fc (AF647)-19553
Goat Anti-Human IgG Fc (FITC)-19553
Human IgG (AF555)-19554
EGFR Mouse mAb (AF555)-19552
EGFR Mouse mAb (AF405)-19552
EGFR Mouse mAb (AF700)-19552